Why CAMP4?
Leadership
Investors
About Our Name
RAP Platform
RNA Actuators
Programmable Therapeutics
Publications & Presentations
Pipeline
Newsroom
Join the Adventure
Recent News
October 10, 2024
CAMP4 Announces Pricing of Initial Public Offering
Read More
Contact Us
Privacy Policy
Menu
Newsroom
Views and missives from the frontier
All
Press Releases
Perspectives
In the News
Videos
July 22, 2022
In the News
Timmerman Report
CAMP4 Raises $100M to Drug ‘the Dark Side of the Genome’
July 20, 2022
In the News
Scrip
CAMP4 Charts A Different Course In RNA-Based Therapeutics
July 20, 2022
In the News
BioSpace
CAMP4 Brings $100M to Target the Dark Side of the Genome with regRNA Platform
October 7, 2021
In the News
Nature Biotechnology
Drug hunters uncloak the non-coding ‘hidden’ genome
July 6, 2021
In the News
Boston Business Journal
What’s in a name? Biotech companies look to stand out from the crowd
June 1, 2018
In the News
Polaris Partners
CAMP4’s trek to speed drug discovery and treat disease through prediction
June 1, 2018
In the News
GenomeWeb
Computational Biology Startup Camp4 Therapeutics Launches With $30M in Series A Funding
May 31, 2018
In the News
Andreessen Horowitz
Camp4
«
1
2
3
»
Media Contact:
PR@camp4tx.com
Top
